STING1 and breast carcinoma: Silencing of STING after mafosfamide treatment of breast cancer cells delayed the appearance of growing colonies of surviving cells, showing that the STING/IFN/STAT1 pathway acts as a cellular mechanism of cancer cell survival and re-growth after the genotoxic stress of chemotherapy (125).